Pharmacology of hemoglobin therapeutics

Journal of Laboratory and Clinical Medicine

Volumn 133, Issue 2, 1999, Pages 112-119

  Gulati, Anil ^a   Barve, Abhijit ^b   Sen, Ananda P ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033083737     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(99)90003-3     Document Type: Article

References (57)

1. 1. Knaus W, Draper E, Wagner D, Zimmerman JE. Prognosis in acute organ system failure. Ann Surg 1985;202:685-93.
2. 2. Estep TN, Bechtel MK, Bush SL, Miller TJ, Szeto S, Webb LE. The purification of hemoglobin solutions by heating. In: Brewer G, editor. Progress in clinical and biological research. New York: Alan R. Liss; 1989. p. 325-36.
3. 3. Estep TN, Bobka EW, Ebeling AA, et al. Novel aspects of diaspirin cross-linked hemoglobin synthesis and purification. Biomater Artif Organs 1989;17:636.
4. 4. Schultz SC, Grady B, Cole F, Hamilton I, Malcolm DS, Burhop K. A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med 1993;122:301-8.
5. 5. Gulati A, Sen AP, Sharma AC, Singh G. Role of ET and NO in resuscitative effect of diaspirin cross-linked hemoglobin after hemorrhage in rat. Am J Physiol 1997;273:H827-36.
6. 6. Sharma AC, Singh G, Gulati A. Role of NO mechanism in cardiovascular effects of diaspirin cross-linked hemoglobin in anesthetized rats. Am J Physiol 1995;269:H1379-88.
7. 7. Katsuyama SS, Cole DJ, Drummond JC, Bradley K. Nitric oxide mediates the hypertensive response to a modified hemoglobin solution (DCLHb) in rats. Artif Cells Blood Substit Immobil Biotechnol 1994;22:1-7.
8. 8. Gulati A, Rebello S. Role of adrenergic mechanisms in the pressor effect of diaspirin cross-linked hemoglobin. J Lab Clin Med 1994;124:125-33.
9. 9. Gulati A, Sharma AC. Prazosin blocks the pressor but not the regional circulatory effects of diaspirin cross-linked hemoglobin. Life Sci 1994;55:121-30.
10. 10. Sharma AC, Gulati A. Yohimbine modulates diaspirin cross-linked hemoglobin-induced systemic hemodynamics and regional circulatory effects. Crit Care Med 1995;23:874-84.
11. 11. Kida Y, Iwata S, Gyoutoku Y, Aikou A, Yamakawa T, Nishi K. Vascular responsiveness to various vasoactive substances after exchange transfusion with pyridoxylated hemoglobin polyoxyethylene conjugate (PHP) solution in anesthetized rats. Artif Organs 1991;15:5-14.
12. 12. Gulati A, Singh G, Rebello S, Sharma AC. Effect of diaspirin cross-linked and stroma-reduced hemoglobin on mean arterial pressure and endothelin-1 concentration in rats. Life Sci 1995;56:1433-42.
13. 13. Gulati A, Sharma AC, Singh G. Role of endothelin in the cardiovascular effects of diaspirin cross-linked and stroma reduced hemoglobin. Crit Care Med 1996;24:137-47.
14. 14. Jones CJH, Defily DV, Patterson JL, Chilian WM. Endothelium-dependent relaxation competes with alpha-1-adrenergic and alpha-2-adrenergic constriction in the canine epicardial coronary microcirculation. Circ 1993;87:1246-74.
15. 15. Morita-Tsuzuki Y, Hardebo JE, Bouskela E. Inhibition of nitric oxide synthesis attenuates the cerebral blood flow response to stimulation of postganglionic parasympathetic nerves in the rat. J Cereb Blood Flow Metab 1993;13:993-7.
16. 16. Fernandez N, Garcia JL, Garcia-Villalon AL, Monge L, Gomez B, Dieguez G. Cerebral blood flow and cerebrovascular reactivity after inhibition of nitric oxide synthesis in conscious goats. Br J Pharmacol 1993;110:428-34.
17. 17. Thiemermann C, Szabo C, Mitchell JA, Vane JR. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc Natl Acad Sci 1993;90:267-71.
18. 18. Wennmalm A, Benthin G, Petersson A-S. Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin. Br J Pharmacol 1992;106:507-8.
19. 19. Toda N, Kitamura Y, Okamura T. Neural mechanisms of hypertension by nitric oxide synthase inhibitor in dogs. Hypertension 1993;21:3-8.
20. 20. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;40:109-42.
21. 21. Brady AJB, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 1993;265:H176-82.
22. 22. Kida Y, Maeda M, Iwata S, Iwashita Y, Goto K, Nishi K. Effects of pyridoxylated hemoglobin polyoxyethylene conjugate and other hemoglobin-related substances on arterial blood pressure in anesthetized and conscious rats. Artif Organs 1995;19:117-28.
23. 23. Lee R, Neya K, Svizzero TA, Vlahkes GJ. Limitations of the efficacy of hemoglobin based oxygen carrying solutions. Am J Physiol 1995;79:236-42.
24. 24. Thompson A, McGarry A, Robert Valeri C, Lieberthal W. Stroma-free hemoglobin increases blood pressure and glomerular filtration rate in hypotensive rats. J Appl Physiol 1994;77:2348-54.
25. 25. Gould SA, Moss GS. Clinical development of human polymerized hemoglobin as a blood substitute. World J Surg 1996;20:1200-7.
26. 26. Conver CD, Lejeune L, Shunn K, Gilbert C, Shorr R. Physiological effect of polyethylene glycol conjugation on stroma-free bovine hemoglobin in conscious dogs after partial exchange transfusion. Artif Organs 1997;21:369-78.
27. 27. Viele MK, Weiskopt RB, Fischer D. Recombinant human hemoglobin does not affect renal function in humans: analysis of safety and pharmacokinetics. Anaesthesiology 1997;86:848-58.
28. 28. Rioux F, Drapeau G, Marceau F. Recombinant human hemoglobin (rHb 1.1) selectively inhibits vasorelaxation elicited by nitric oxide donors in rabbit isolated aortic rings. J Cardiovasc Pharmacol 1995;25:587-94.
29. 29. Marquerdt DA, Epp JK, Vincelette J, Suniga M, Doyle MP, Anthony-Cahill SJ. Characterization of a 260 kDa tetrahemoglobin obtained by chemical cross-linking of a cysteine containing dihemoglobin. Artificial Blood 1997;5:3.
30. 30. Barve A, Sen AP, Saxena PR, Gulati A. Dose response effect of diaspirin cross-linked hemoglobin (DCLHb) in systemic hemodynamics and regional circulation in rats. Artif Cells Blood Substit Immobil Biotechnol 1997;25:75-84.
31. 31. Malcolm DS, Hamilton J, Schultz SC, Cole F, Burhop K. Characterization of the hemodynamic response to intravenous diaspirin cross-linked hemoglobin solutions in rats. Artif Cells Blood Substit Immobil Biotechnol 1994;22:91-107.
32. 32. Liard JF, Kunert MP. Hemodynamic changes induced by low blood oxygen affinity in dogs. Am J Physiol 1993;264:396-401.
33. 33. Jia L, Bonaventura C, Bonaventura J, Stamler JS. S-nitrosohemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996;380:221-6.
34. 34. Murray JA, Ledlow A, Launspach J, Evans D, Loveday M, Conklin J. The effects of recombinant hemoglobin on esophageal motor function in humans. Gastroenterology 1995;109:1241-8.
35. 35. Thiemermann C. The role of the L-arginine: nitric oxide pathway in circulatory shock. Adv Pharmacol 1994;28:45-79.
36. 36. Sen AP, Dong Y, Saxena PR, Gulati A. Modulation of resuscitation effect of diaspirin cross-linked hemoglobin by L-NAME in rats. Shock 1998;9:223-30.
37. 37. Harbrecht BG, Wu B, Watkins SC, Marshall HP Jr, Peitzman AB, Billiar TR. Inhibition of nitric oxide synthase during hemorrhagic shock increases hepatic injury. Shock 1995;4:332-7.
38. 38. Brown IP, Williams RL, McKirnan MD, Limjoco UR, Gray CG. Nitric oxide synthesis inhibition does not improve the hemodynamic response to hemorrhagic shock in dehydrated conscious swine. Shock 1995;3:292-8.
39. 39. Ventura S, Ludbrook J. N-nitro-L-arginine methyl ester blocks the decompensatory phase of acute hypovolaemia in conscious rabbits by a brainstem mechanism. Eur J Pharmacol 1995;277:265-9.
40. 40. Lieberthal W, McGarry AE, Sheils J, Valeri CR. Nitric oxide inhibition in rats improves blood pressure and renal function during hypovolemic shock. Am J Physiol 1991;261:F868-72.
41. 41. Zingarelli B, Squadrito F, Altavilla D, et al. Evidence for a role of nitric oxide in hypovolemic hemorrhagic shock. J Cardiovasc Pharmacol 1992;19:982-6.
42. 42. Chyu K-Y, Guth PH, Ross G. Effect of N-nitro-L-arginine methyl ester on arterial pressure and on vasodilator and vasoconstrictor responses: influence of initial vascular tone. Eur J Pharmacol 1992;212:159-64.
43. G-methyl-L-arginine restores arterial pressure in hemorrhaged rats. Circ Shock 1993;40:47-52.
44. 44. Koch MA, Hasser EM, Schadt JC. Influence of nitric oxide on the hemodynamic response to hemorrhage in conscious rabbits. Am J Physiol 1995;268:R171-82.
45. 45. Lemon DD, Doherty DH, Vincelette JE, Doyle MP. Oxygen delivery by recombinant human hemoglobin variants. Artificial Blood 1997;5:20.
46. 46. Bilello K, Schultz S, Powell C, Jaffin J, Cole F, Malcolm D. Diaspirin cross-linked hemoglobin (DCLHb): control of pressor effect with anti-hypertensive agents. Artif Cells Blood Substit Immobil Biotechnol 1994;22:819-25.
47. 47. Flint LM, Cryer HM, Simpson CJ, Harris PD. Microcirculatory norepinephrine constrictor response in hemorrhagic shock. Surgery 1984;96:240-7.
48. 48. Hutchins PM, Goldstone J, Wells R. Effects of hemorrhagic shock on the microvasculature of skeletal muscle. Microvasc Res 1973;5:131-40.
49. 49. Zingarelli B, Caputi AP, Di Rosa M. Dexamethasone prevents vascular failure mediated by nitric oxide in hemorrhagic shock. Shock 1994;2:210-5.
50. 50. Ohlstein EH, Storer BL. Oxyhemoglobin stimulation of endothelin production in cultured endothelial cells. J Neurosurg 1992;77:274-8.
51. 51. Vemulapalli S, Chiu PJS, Griscti K, Brown A, Kurowski S, Sybertz EJ. Phosphoramidon does not inhibit endogenous endothelin-1 release stimulated by hemorrhage, cytokines and hypoxia in rats. Eur J Pharmacol 1994;257:95-102.
52. 52. Zimmerman RS, Maymind M, Barbee RW. Endothelin blockade lowers total peripheral resistance in hemorrhagic shock recovery. Hypertension 1994;23:205-10.
53. 53. Chang H, Wu G-J, Wang S-M, Hung C. Plasma endothelin level changes during hemorrhagic shock. J Trauma 1993;35:825-33.
54. 54. Sharma AC, Singh G, Gulati A. Role of nitric oxide mechanism in the cardiovascular effects of diaspirin cross-linked hemoglobin in anaesthetized rats. Am J Physiol 1995;269:H1379-88.
55. 55. Gulati A. Recent advances in the development of haemoglobin-based blood substitutes. Exp Opin Invest Drugs 1997;6:1659-69.
56. 56. Gould SA, Sehgal LR, Sehgal HL, Moss GS. The development of hemoglobin solutions as red cell substitutes: hemoglobin solutions. Transfus Sci 1995;16:5-17.
57. 57. Abassi Z, Kotob S, Pieruzzi F, et al. Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats. J Lab Clin Med 1997;129:603-10.